Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)

Overview of attention for article published in Cancer (0008543X), August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 42,344 followers.

Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS) @JournalCancer #ASH21 @DrHKantarjian https://t.co/xvgPZMJecN

New article: Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS) https://t.co/gOB3PSRMbe #AML #leusm #hematology https://t.co/lv4PVA7u9g

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.